What is the Difference Between Biotech versus Medtech?
Post written by: BioTech Health X
You May Also Like
AstraZeneca (AZN) Targets $80 Billion Revenue by 2030
Table of Contents Hide A Turning Point in U.S. Drug Policy and AstraZeneca’s Market Position$50 Billion U.S. Expansion…
BioCryst Pharmaceuticals (BCRX) Posted Q2 49.5% Revenue Surge
Table of Contents Hide Heavy Reliance on ORLADEYO Raises Concentration RiskEarnings Beat Masks Longer-Term Profitability ConcernsInstitutional Buying Creates…
PharmaCyte Biotech Announces Uplist to Nasdaq Capital Market and Public Offering
Biotechnology company PharmaCyte Biotech, Inc. (OTCQB: PMCBD), a company concentrated on creating cellular therapies for cancer cells and…
BeOne Medicines (ONC) is Quietly Taking Over the Global Cancer Drug Market
Table of Contents Hide Promising ASCO 2025 Data Signals a Breakthrough in Breast Cancer R&DBG-C9074: A Next-Generation Antibody-Drug…
Serina (SER)’s Parkinson’s Drug Gets FDA Support—Stock Investors Go Wild
Table of Contents Hide Serina Therapeutics Stock Surges on FDA FeedbackAddressing Unmet Needs in Advanced Parkinson’s DiseaseFDA Support…
Is Niagen Bioscience (NAGE) the Best Pure-Play Bet on NAD+ and Healthy Aging?
Table of Contents Hide A Global Authority on NAD+ Science Gains Renewed Attention From the MarketBuilding a Bioscience…